{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:43:29Z","timestamp":1791481409155,"version":"4.3.4"},"reference-count":174,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontierspartnerships.org"],"crossmark-restriction":true},"short-container-title":["Transpl. Int."],"abstract":"<jats:p>Liver transplantation for cholangiocarcinoma (CCA) shifted from a contraindication to a promising therapeutic option for selected patients. Advances in neoadjuvant therapy and refined selection criteria resulted in long-term outcomes comparable to other accepted oncologic indications, particularly in perihilar CCA managed with standardized protocols and in intrahepatic CCA with favorable tumor biology. The future challenge is to develop a multiparametric biological selection, blending clinical, functional, histopathologic, molecular, and radiologic parameters to identify candidates with indolent disease behavior, thus maximizing oncologic benefit while ensuring appropriate use of limited graft resources.<\/jats:p>","DOI":"10.3389\/ti.2026.15786","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T05:10:12Z","timestamp":1778130612000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Present and future of liver transplantation for cholangiocellular carcinoma: moving toward personalized multiparametric transplantability patterns"],"prefix":"10.3389","volume":"39","author":[{"given":"Umberto","family":"Cillo","sequence":"first","affiliation":[{"name":"Department of Surgery, Oncology and Gastroenterology (DiSCOG), University of Padua","place":["Padua, Italy"]},{"name":"Hepato-Bilio-Pancreatic Surgery and Liver Transplantation Unit, Azienda Ospedale Universita Padova","place":["Padua, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Furlanetto","sequence":"additional","affiliation":[{"name":"Department of Surgery, Oncology and Gastroenterology (DiSCOG), University of Padua","place":["Padua, Italy"]},{"name":"Hepato-Bilio-Pancreatic Surgery and Liver Transplantation Unit, Azienda Ospedale Universita Padova","place":["Padua, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"Lanari","sequence":"additional","affiliation":[{"name":"Department of Surgery, Oncology and Gastroenterology (DiSCOG), University of Padua","place":["Padua, Italy"]},{"name":"Hepato-Bilio-Pancreatic Surgery and Liver Transplantation Unit, Azienda Ospedale Universita Padova","place":["Padua, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Nieddu","sequence":"additional","affiliation":[{"name":"Department of Surgery, Oncology and Gastroenterology (DiSCOG), University of Padua","place":["Padua, Italy"]},{"name":"Hepato-Bilio-Pancreatic Surgery and Liver Transplantation Unit, Azienda Ospedale Universita Padova","place":["Padua, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Rosso","sequence":"additional","affiliation":[{"name":"Department of Surgery, Oncology and Gastroenterology (DiSCOG), University of Padua","place":["Padua, Italy"]},{"name":"Hepato-Bilio-Pancreatic Surgery and Liver Transplantation Unit, Azienda Ospedale Universita Padova","place":["Padua, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Enrico","family":"D\u2019Amico","sequence":"additional","affiliation":[{"name":"Department of Surgery, Oncology and Gastroenterology (DiSCOG), University of Padua","place":["Padua, Italy"]},{"name":"Hepato-Bilio-Pancreatic Surgery and Liver Transplantation Unit, Azienda Ospedale Universita Padova","place":["Padua, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Bassi","sequence":"additional","affiliation":[{"name":"Hepato-Bilio-Pancreatic Surgery and Liver Transplantation Unit, Azienda Ospedale Universita Padova","place":["Padua, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Gringeri","sequence":"additional","affiliation":[{"name":"Department of Surgery, Oncology and Gastroenterology (DiSCOG), University of Padua","place":["Padua, Italy"]},{"name":"Hepato-Bilio-Pancreatic Surgery and Liver Transplantation Unit, Azienda Ospedale Universita Padova","place":["Padua, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"773","DOI":"10.3390\/cancers17050773","article-title":"Expanding indications in transplant oncology","volume":"17","author":"Allkushi","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"820","DOI":"10.3390\/diagnostics15070820","article-title":"Evolving transplant oncology: evolving criteria for better decision-making","volume":"15","author":"Karageorgos","year":"2025","journal-title":"Diagnostics"},{"key":"B3","first-page":"100965","article-title":"Transplant oncology \u2013Current indications and strategies to advance the field","volume-title":"JHEP Rep","author":"Krendl","year":"2023"},{"key":"B4","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jhep.2023.03.010","volume":"79","year":"2023","journal-title":"J Hepatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.annonc.2022.10.506","article-title":"Biliary tract cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up \u2606","volume":"34","author":"Vogel","year":"2023","journal-title":"Ann Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000006773","article-title":"Recommendations on perihilar cholangiocarcinoma. The milan jury-based consensus","author":"Pfister","year":"2025","journal-title":"Ann Surg"},{"key":"B7","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/SLA.0000000000004071","article-title":"Transplant oncology in primary and metastatic liver tumors: principles, evidence, and opportunities","volume":"273","author":"Sapisochin","year":"2021","journal-title":"Ann Surg"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1097\/TP.0000000000003118","article-title":"Liver transplantation for colorectal and neuroendocrine liver metastases and hepatoblastoma. Working group report from the ILTS transplant oncology consensus conference","volume":"104","author":"Hibi","year":"2020","journal-title":"Transplantation"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/S0140-6736(24)01595-2","article-title":"Liver transplantation plus chemotherapy versus chemotherapy alone in patients with permanently unresectable colorectal liver metastases (TransMet): results from a multicentre, open-label, prospective, randomised controlled trial","volume":"404","author":"Adam","year":"2024","journal-title":"The Lancet"},{"key":"B10","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.dld.2024.12.003","article-title":"Hepatocellular carcinoma: revising the surgical approach in light of the concept of multiparametric therapeutic hierarchy","volume":"57","author":"Cillo","year":"2025","journal-title":"Dig Liver Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/j.jhep.2022.07.022","article-title":"Current epidemiology of cholangiocarcinoma in Western countries","volume":"77","author":"Vithayathil","year":"2022","journal-title":"J Hepatol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"101170","DOI":"10.1016\/j.lanepe.2024.101170","article-title":"New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe","volume":"50","author":"Rimassa","year":"2025","journal-title":"The Lancet Reg Health - Europe"},{"key":"B14","doi-asserted-by":"publisher","first-page":"108248","DOI":"10.1016\/j.ejso.2024.108248","article-title":"Surgical management, including the role of transplantation, for intrahepatic and peri-hilar cholangiocarcinoma","volume":"51","author":"Malik","year":"2025","journal-title":"Eur J Surg Oncol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.3390\/cancers16111946","article-title":"Cholangiocarcinoma: the current status of surgical options including liver transplantation","volume":"16","author":"Esmail","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1097\/LVT.0000000000000589","article-title":"The 2024 ILTS-ILCA consensus recommendations for liver transplantation for HCC and intrahepatic cholangiocarcinoma","volume":"31","author":"Kodali","year":"2025","journal-title":"Liver Transplant"},{"key":"B17","doi-asserted-by":"publisher","first-page":"996710","DOI":"10.3389\/fonc.2022.996710","article-title":"Intrahepatic cholangiocarcinoma: the role of liver transplantation, adjunctive treatments, and prognostic biomarkers","volume":"12","author":"Connor","year":"2022","journal-title":"Front Oncol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/LIV.14089","article-title":"Surgery for cholangiocarcinoma","volume":"39","author":"Cillo","year":"2019","journal-title":"Liver Int"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.jhep.2021.12.010","article-title":"Cholangiocarcinoma landscape in Europe: diagnostic, prognostic and therapeutic insights from the ENSCCA registry","volume":"76","author":"Izquierdo-Sanchez","year":"2022","journal-title":"J Hepatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1245\/s10434-023-14880-8","article-title":"Benchmarks in liver resection for intrahepatic cholangiocarcinoma","volume":"31","author":"Alaimo","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1097\/SLA.0000000000005103","article-title":"Perihilar cholangiocarcinoma \u2013 novel benchmark values for surgical and oncological outcomes from 24 expert centers","volume":"274","author":"Mueller","year":"2021","journal-title":"Ann Surg"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e235","DOI":"10.1093\/bjs\/znab095","article-title":"Ante situm liver surgery using machine perfusion liver preservation: pilot human experience","volume":"108","author":"Cillo","year":"2021","journal-title":"Br J Surg"},{"key":"B23","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s13304-021-01041-3","article-title":"Robotic hepatectomy and biliary reconstruction for perihilar cholangiocarcinoma: a pioneer western case series","volume":"73","author":"Cillo","year":"2021","journal-title":"Updates Surg Springer Sci Business Media Deutschland GmbH"},{"key":"B24","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1586\/egh.10.45","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"4","author":"Weigt","year":"2010","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"EVIDoa2200015","DOI":"10.1056\/evidoa2200015","article-title":"Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer","volume":"1","author":"Oh","year":"2022","journal-title":"NEJM Evid"},{"key":"B26","doi-asserted-by":"publisher","first-page":"101290","DOI":"10.1016\/j.jhepr.2024.101290","article-title":"Recent advances in systemic therapy for advanced biliary tract cancer: a systematic review and meta-analysis using reconstructed RCT survival data","volume":"7","author":"Li","year":"2025","journal-title":"JHEP Rep"},{"key":"B27","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/S2468-1253(24)00095-5","article-title":"Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study","volume":"9","author":"Oh","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/S0140-6736(23)00727-4","article-title":"Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"401","author":"Kelley","year":"2023","journal-title":"The Lancet"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1097\/HEP.0000000000000760","article-title":"Neoadjuvant and adjuvant therapy for biliary tract cancer: advances and limitations","volume":"82","author":"Wilbur","year":"2024","journal-title":"Hepatology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"4008","DOI":"10.1200\/JCO.2025.43.16_SUPPL.4008","article-title":"Neoadjuvant chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus immediate radical liver resection alone followed adjuvant therapy in biliary tract cancer: final results from the phase III AIO\/CALGP\/ACO-GAIN-Trial","volume":"43","author":"Goetze","year":"2025","journal-title":"J Clin Oncol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1097\/HEP.0000000000000554","article-title":"Predicting futility of upfront surgery in perihilar cholangiocarcinoma: machine learning analytics model to optimize treatment allocation","volume":"79","author":"Ratti","year":"2024","journal-title":"Hepatology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1111\/tri.12640","article-title":"Portal vein encasement predicts neoadjuvant therapy response in liver transplantation for perihilar cholangiocarcinoma protocol","volume":"28","author":"Bhat","year":"2015","journal-title":"Transpl Int"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1097\/00007890-200004270-00019","article-title":"Liver transplantation for cholangiocarcinoma: results in 207 patients","volume":"69","author":"Meyer","year":"2000","journal-title":"Transplantation"},{"key":"B34","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/01.sla.0000108702.45715.81","article-title":"Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma","volume":"239","author":"Robles","year":"2004","journal-title":"Ann Surg"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1002\/lt.21887","article-title":"Extended bile duct resection and [corrected] liver and transplantation in patients with hilar cholangiocarcinoma: long-term results","volume":"15","author":"Seehofer","year":"2009","journal-title":"Liver Transpl"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1002\/lt.20512","article-title":"Liver transplantation for incidental cholangiocarcinoma: analysis of the Canadian experience","volume":"11","author":"Ghali","year":"2005","journal-title":"Liver Transpl"},{"key":"B37","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1055\/s-2004-828896","article-title":"Liver transplantation for unresectable perihilar cholangiocarcinoma","volume":"24","author":"Heimbach","year":"2004","journal-title":"Semin Liver Dis"},{"key":"B38","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1432-2277.2010.01108.x","article-title":"Liver transplantation for cholangiocarcinoma","volume":"23","author":"Rosen","year":"2010","journal-title":"Transpl Int"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1007\/s13304-024-01889-1","article-title":"The Italian experience on liver transplantation for unresectable peri-hilar cholangiocarcinoma: a national survey and future perspectives","volume":"76","author":"Gringeri","year":"2024","journal-title":"Updates Surg"},{"key":"B40","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/j.1477-2574.2011.00298.x","article-title":"Trans-peritoneal fine needle aspiration biopsy of hilar cholangiocarcinoma is associated with disease dissemination","volume":"13","author":"Heimbach","year":"2011","journal-title":"Hpb"},{"key":"B41","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1053\/j.gastro.2012.04.008","article-title":"Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers","volume":"143","author":"Darwish","year":"2012","journal-title":"Gastroenterology"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1007\/s11605-020-04721-4","article-title":"Liver transplantation for peri-hilar cholangiocarcinoma","volume":"24","author":"Tan","year":"2020","journal-title":"J Gastrointest Surg"},{"key":"B43","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/SLA.0000000000003801","article-title":"Meta-analysis and meta-regression of survival after liver transplantation for unresectable perihilar cholangiocarcinoma","volume":"273","author":"Cambridge","year":"2021","journal-title":"Ann Surg"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e0156127","DOI":"10.1371\/journal.pone.0156127","article-title":"Strict selection alone of patients undergoing liver transplantation for hilar cholangiocarcinoma is associated with improved survival","volume":"11","author":"Mantel","year":"2016","journal-title":"PLoS One"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/bjsopen\/zrad025","article-title":"Role of neoadjuvant chemoradiotherapy in liver transplantation for unresectable perihilar cholangiocarcinoma: Multicentre, retrospective cohort study","volume":"7","author":"Hoogwater","year":"2023","journal-title":"BJS Open"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1097\/HEP.0000000000001449","article-title":"Liver resection with and without vascular resection versus transplantation for de novo perihilar cholangiocarcinoma","volume":"83","author":"Dong","year":"2025","journal-title":"Hepatology"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1002\/lt.21107","article-title":"Vascular complications after orthotopic liver transplantation after neoadjuvant therapy for hilar cholangiocarcinoma","volume":"13","author":"Mantel","year":"2007","journal-title":"Liver Transpl"},{"key":"B48","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/HEP.32771","article-title":"AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma","volume":"77","author":"Bowlus","year":"2023","journal-title":"Hepatology"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1016\/j.hpb.2021.04.011","article-title":"Outcome after resection for perihilar cholangiocarcinoma in patients with primary sclerosing cholangitis: an international multicentre study","volume":"23","author":"Jansson","year":"2021","journal-title":"HPB"},{"key":"B50","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1477-2574.2011.00305.x","article-title":"History of pancreaticoduodenectomy: early misconceptions, initial milestones and the pioneers","volume":"13","author":"Are","year":"2011","journal-title":"HPB"},{"key":"B51","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s002689900014","article-title":"Outcome of major hepatectomy with pancreatoduodenectomy for advanced biliary malignancies","volume":"20","author":"Miyagawa","year":"1996","journal-title":"World J Surg"},{"key":"B52","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/SLA.0b013e31826029ca","article-title":"Hepatopancreatoduodenectomy for cholangiocarcinoma: a single-center review of 85 consecutive patients","volume":"256","author":"Ebata","year":"2012","journal-title":"Ann Surg"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1245\/s10434-020-09303-x","article-title":"Liver transection-first approach in hepatopancreatoduodenectomy for hilar cholangiocarcinoma: a safe and secure technique for the early assessment of curable resection and vascular reconstruction","volume":"28","author":"Ishii","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s11605-018-3923-6","article-title":"Surgical technique of pancreatic parenchyma transection-delayed approach (PPTDA) in hepatopancreatoduodenectomy for hilar cholangiocarcinoma","volume":"23","author":"Chiba","year":"2019","journal-title":"J Gastrointest Surg"},{"key":"B55","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1245\/s10434-023-14406-2","article-title":"The Short- and long-term surgical results of consecutive hepatopancreaticoduodenectomy for wide-spread biliary malignancy","volume":"31","author":"Yoshimi","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"6531","DOI":"10.1245\/s10434-025-17515-2","article-title":"Hepatopancreatoduodenectomy for extrahepatic cholangiocarcinoma: a series of 100 consecutive cases from an expert center in Japan","volume":"32","author":"Sugiura","year":"2025","journal-title":"Ann Surg Oncol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1245\/s10434-020-09209-8","article-title":"Safety and oncological benefit of hepatopancreatoduodenectomy for advanced extrahepatic cholangiocarcinoma with horizontal tumor spread: shinshu university experience","volume":"28","author":"Shimizu","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/jhbp.918","article-title":"Mortality, morbidity, and failure to rescue in hepatopancreatoduodenectomy: an analysis of patients registered in the national clinical database in Japan","volume":"28","author":"Endo","year":"2021","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"B59","doi-asserted-by":"publisher","first-page":"109633","DOI":"10.1016\/j.ejso.2025.109633","article-title":"Long-term outcomes of hepatopancreatoduodenectomy for perihilar cholangiocarcinoma: a comparative study with conventional hepatectomy","volume":"51","author":"Kiritani","year":"2025","journal-title":"Eur J Surg Oncol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1245\/s10434-025-18665-z","article-title":"Reassessing the role of hepatopancreatoduodenectomy in advanced biliary tract cancer: a systematic review and single-arm meta-analysis of modern case series","volume":"33","author":"Yasukawa","year":"2026","journal-title":"Ann Surg Oncol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1097\/SLA.0000000000002059","article-title":"Hepatopancreaticoduodenectomy for biliary cancer: strategies for near-zero operative mortality and acceptable long-term outcome","volume":"267","author":"Aoki","year":"2018","journal-title":"Ann Surg"},{"key":"B62","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.hpb.2019.08.010","article-title":"Hepatopancreatoduodenectomy in North America: are the outcomes acceptable?","volume":"22","author":"Welch","year":"2020","journal-title":"HPB"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/j.hpb.2019.12.008","article-title":"Hepatopancreatoduodenectomy \u2013a controversial treatment for bile duct and gallbladder cancer from a European perspective","volume":"22","author":"D\u2019Souza","year":"2020","journal-title":"HPB"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1002\/lt.21932","article-title":"Liver transplantation and pancreatic resection: a single-center experience and a review of the literature","volume":"15","author":"Stauffer","year":"2009","journal-title":"Liver Transpl"},{"key":"B65","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1111\/j.1600-6143.2008.02346.x","article-title":"Sequential pancreaticoduodenectomy after living donor liver transplantation for cholagiocacinoma","volume":"8","author":"Soejima","year":"2008","journal-title":"Am J Transplant"},{"key":"B66","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.jamcollsurg.2003.06.001","article-title":"Combined adult-to-adult living donor right lobe liver transplantation and pancreatoduodenectomy for distal bile duct adenocarcinoma in a patient with primary sclerosing cholangitis","volume":"197","author":"Varotti","year":"2003","journal-title":"J Am Coll Surg"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.transproceed.2011.01.140","article-title":"Neoadjuvant therapy protocol and liver transplantation in combination with pancreatoduodenectomy for the treatment of hilar cholangiocarcinoma occurring in a case of primary sclerosing cholangitis: case report with a more than 8-year disease-free surviva","volume":"43","author":"Gringeri","year":"2011","journal-title":"Transpl Proc"},{"key":"B68","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/lt.21287","article-title":"Long-term, tumor-free survival after radiotherapy combining hepatectomy-whipple en bloc and orthotopic liver transplantation for early-stage hilar cholangiocarcinoma","volume":"14","author":"Wu","year":"2008","journal-title":"Liver Transplant"},{"key":"B69","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/tri.12401","article-title":"Total hepatectomy, pancreatoduodenectomy, and living donor liver transplantation using innovative vascular reconstruction for unresectable cholangiocarcinoma","volume":"28","author":"Moon","year":"2015","journal-title":"Transpl Int"},{"key":"B70","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/jhbp.12121","article-title":"Safety and efficacy of living donor liver transplantation for unresectable perihilar cholangiocarcinoma: a single center prospective study","volume":"32","author":"Ito","year":"2025","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1007\/s13304-024-01919-y","article-title":"Advocating for a \u201c shift - to - left \u201d in transplant oncology: left grafts, RAPID and dual graft","volume":"77","author":"Cillo","year":"2024","journal-title":"Updates Surg"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1097\/LVT.0000000000000574","article-title":"Exploring auxiliary liver transplantation in the era of transplant oncology-A proposal for a new liver splitting program (ALERT-50)","volume":"31","author":"Gringeri","year":"2025","journal-title":"Liver Transpl"},{"key":"B73","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jamcollsurg.2019.12.037","article-title":"Living donor liver transplantation for perihilar cholangiocarcinoma: outcomes and complications","volume":"231","author":"Tan","year":"2020","journal-title":"J Am Coll Surg"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0220527","article-title":"Comparison between liver transplantation and resection for hilar cholangiocarcinoma: a systematic review and meta-analysis","volume":"14","author":"Moris","year":"2019","journal-title":"PLoS One"},{"key":"B75","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1097\/SLA.0000000000005641","article-title":"Liver transplantation as a new standard of care in patients with perihilar cholangiocarcinoma? Results from an international benchmark study","volume":"276","author":"Breuer","year":"2022","journal-title":"Ann Surg"},{"key":"B76","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/SLA.0000000000002477","article-title":"Defining benchmarks in liver transplantation: a multicenter outcome analysis determining best achievable results","volume":"267","author":"Muller","year":"2018","journal-title":"Ann Surg"},{"key":"B77","article-title":"From clinical heterogeneity to national standardization in liver transplantation for perihilar cholangiocarcinoma: the LITALHICA protocol","author":"Gringeri","year":"2026","journal-title":"Transplantation"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1097\/01.tp.0000253551.43583.d1","article-title":"Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma","volume":"82","author":"Heimbach","year":"2006","journal-title":"Transplantation"},{"key":"B79","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1002\/hep.25629","article-title":"Predictors of pretransplant dropout and posttransplant recurrence in patients with perihilar cholangiocarcinoma","volume":"56","author":"Murad","year":"2012","journal-title":"Hepatology"},{"key":"B80","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jamcollsurg.2015.01.064","article-title":"Is liver transplantation appropriate for patients with potentially resectable de novo hilar cholangiocarcinoma?","volume":"221","author":"Croome","year":"2015","journal-title":"J Am Coll Surg"},{"key":"B81","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1097\/SLA.0000000000002574","article-title":"Transplantation versus resection for hilar cholangiocarcinoma: an argument for shifting treatment paradigms for resectable disease","volume":"267","author":"Ethun","year":"2018","journal-title":"Ann Surg"},{"key":"B82","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1097\/TP.0000000000003114","article-title":"Neoadjuvant chemoradiotherapy and liver transplantation for unresectable hilar cholangiocarcinoma: the Irish experience of the Mayo protocol","volume":"104","author":"Zaborowski","year":"2020","journal-title":"Transplantation"},{"key":"B83","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1097\/SLA.0000000000000494","article-title":"Intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma in patients undergoing liver transplantation: a spanish matched cohort multicenter study","volume":"259","author":"Sapisochin","year":"2014","journal-title":"Ann Surg"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1002\/hep.28744","article-title":"Liver transplantation for \u201cvery early\u201d intrahepatic cholangiocarcinoma: international retrospective study supporting a prospective assessment","volume":"64","author":"Sapisochin","year":"2016","journal-title":"Hepatology"},{"key":"B85","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1097\/TP.0000000000003539","article-title":"Liver transplantation for intrahepatic cholangiocarcinoma: a meta-analysis and meta-regression of survival rates","volume":"105","author":"Ziogas","year":"2021","journal-title":"Transplantation"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1016\/J.CGH.2024.09.028","article-title":"Prevalence of chronic liver disease in cholangiocarcinoma: a meta-analysis","volume":"23","author":"Tham","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/S12876-023-02710-W","article-title":"Cirrhosis in intrahepatic cholangiocarcinoma: prognostic importance and impact on survival","volume":"23","author":"Thakral","year":"2023","journal-title":"BMC Gastroenterol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/lt.25737","article-title":"Analysis of liver resection versus liver transplantation on outcome of small intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma in the setting of cirrhosis","volume":"26","author":"De Martin","year":"2020","journal-title":"Liver Transplant"},{"key":"B89","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1001\/ARCHSURG.2011.116","article-title":"Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma: a 24-year experience in a single center","volume":"146","author":"Hong","year":"2011","journal-title":"Arch Surg"},{"key":"B90","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.jamcollsurg.2010.12.005","article-title":"Predictive index for tumor recurrence after liver transplantation for locally advanced intrahepatic and hilar cholangiocarcinoma","volume":"212","author":"Hong","year":"2011","journal-title":"J Am Coll Surg"},{"key":"B91","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/LT.26285","article-title":"A 3-Decade, single-center experience of liver transplantation for cholangiocarcinoma: impact of era, tumor size, location, and neoadjuvant therapy","volume":"28","author":"Ito","year":"2022","journal-title":"Liver Transpl"},{"key":"B92","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S2468-1253(18)30045-1","article-title":"Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series","volume":"3","author":"Lunsford","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/ajt.16906","article-title":"Survival following liver transplantation for locally advanced, unresectable intrahepatic cholangiocarcinoma","volume":"22","author":"McMillan","year":"2022","journal-title":"Am J Transplant"},{"key":"B94","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.hbpd.2023.07.007","article-title":"Liver transplantation as an alternative for the treatment of intrahepatic cholangiocarcinoma: past, present, and future directions","volume":"23","author":"Kodali","year":"2024","journal-title":"Hepatobiliary Pancreat Dis Int Elsevier (Singapore) Pte Ltd."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.3390\/curroncol29030157","article-title":"Living donor liver transplantation for intrahepatic cholangiocarcinoma","volume":"29","author":"Rauchfu\u00df","year":"2022","journal-title":"Curr Oncol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/JHBP.896","article-title":"Incidental intrahepatic cholangiocarcinoma in patients undergoing liver transplantation: a multi-center study in Japan","volume":"28","author":"Hara","year":"2021","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"B97","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.amsu.2020.07.028","article-title":"Living donor liver transplantation for intra hepatic cholangiocarcinoma","volume":"57","author":"Hafeez Bhatti","year":"2020","journal-title":"Ann Med Surg"},{"key":"B98","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.3390\/JCM12082807","article-title":"Living-donor liver transplant and improved post-transplant survival in patients with primary sclerosing cholangitis","volume":"12","author":"Sierra","year":"2023","journal-title":"J Clin Med"},{"key":"B99","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/BF00316984","article-title":"Surgical treatment of cholangiocellular carcinoma","volume":"19","author":"Pichlmayl","year":"1995","journal-title":"World J Surg"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1046\/j.1365-2168.2000.01532.x","article-title":"Retrospective analysis of prognostic factors after liver resection and transplantation for cholangiocellular carcinoma","volume":"87","author":"Weimann","year":"2000","journal-title":"Br J Surg"},{"key":"B101","doi-asserted-by":"publisher","first-page":"42","DOI":"10.12659\/AOT.901504","article-title":"Clinicopathological features and prognosis of intrahepatic cholangiocarcinoma after liver transplantation and resection","volume":"22","author":"Jung","year":"2017","journal-title":"Ann Transpl"},{"key":"B102","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1002\/jso.26370","article-title":"A comparison of surgical resection and liver transplantation in the treatment of intrahepatic cholangiocarcinoma in the era of modern chemotherapy: an analysis of the national cancer database","volume":"123","author":"Hue","year":"2021","journal-title":"J Surg Oncol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.surg.2021.09.034","article-title":"Intrahepatic cholangiocarcinoma: is there a role for liver transplantation?","volume":"171","author":"Kim","year":"2022","journal-title":"Surgery (United States)"},{"key":"B104","doi-asserted-by":"publisher","first-page":"3610","DOI":"10.1002\/cncr.34436","article-title":"Disparities in curative treatments and outcomes for early stage intrahepatic cholangiocarcinoma in the United States","volume":"128","author":"Lee","year":"2022","journal-title":"Cancer"},{"key":"B105","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.gassur.2024.02.029","article-title":"Contemporary trends and outcomes after liver transplantation and resection for intrahepatic cholangiocarcinoma","volume":"28","author":"Howell","year":"2024","journal-title":"J Gastrointest Surg"},{"key":"B106","doi-asserted-by":"publisher","first-page":"10630","DOI":"10.1038\/s41598-023-37896-2","article-title":"Liver transplantation for intrahepatic cholangiocarcinoma: a propensity score-matched analysis","volume":"13","author":"Huang","year":"2023","journal-title":"Sci Rep"},{"key":"B107","doi-asserted-by":"publisher","first-page":"znaf054","DOI":"10.1093\/bjs\/znaf054","article-title":"Liver transplantation for locally advanced non-resectable intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: early results from the TESLA trial","volume":"112","author":"Yaqub","year":"2025","journal-title":"Br J Surg"},{"key":"B108","doi-asserted-by":"publisher","first-page":"13641","DOI":"10.3389\/ti.2024.13641","article-title":"Liver transplantation for intrahepatic cholangiocarcinoma after chemotherapy and radioembolization: an intention-to-treat study","volume":"37","author":"Maspero","year":"2024","journal-title":"Transpl Int"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1016\/J.AJT.2024.06.009","article-title":"The emerging role of generative artificial intelligence in transplant medicine","volume":"24","author":"Deeb","year":"2024","journal-title":"Am J Transplant"},{"key":"B110","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1038\/S41591-025-03801-9","article-title":"Reshaping transplantation with AI, emerging technologies and xenotransplantation","volume":"31","author":"Loupy","year":"2025","journal-title":"Nat Med"},{"key":"B111","doi-asserted-by":"publisher","first-page":"34","DOI":"10.20517\/2394-5079.2023.37","article-title":"Genomic alterations in intrahepatic cholangiocarcinoma","volume":"9","author":"Young","year":"2023","journal-title":"Hepatoma Res"},{"key":"B112","doi-asserted-by":"publisher","first-page":"260","DOI":"10.7150\/THNO.63417","article-title":"Driver mutations of intrahepatic cholangiocarcinoma shape clinically relevant genomic clusters with distinct molecular features and therapeutic vulnerabilities","volume":"27","author":"Wang","year":"2022","journal-title":"Theranostics"},{"key":"B113","doi-asserted-by":"publisher","first-page":"6087","DOI":"10.1038\/NCOMMS7087","article-title":"Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma","volume":"6","author":"Sia","year":"2015","journal-title":"Nat Commun"},{"key":"B114","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1200\/JCO.2017.75.5009","article-title":"Phase II study of BGJ398 in patients with FGFR-altered advanced cholangiocarcinoma","volume":"36","author":"Javle","year":"2018","journal-title":"J Clin Oncol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S1470-2045(20)30109-1","article-title":"Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study","volume":"21","author":"Abou-Alfa","year":"2020","journal-title":"Lancet Oncol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S2468-1253(21)00196-5","article-title":"Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study","volume":"6","author":"Javle","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/S1470-2045(20)30157-1","article-title":"Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study","volume":"21","author":"Abou-Alfa","year":"2020","journal-title":"Lancet Oncol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1001\/JAMAONCOL.2021.3836","article-title":"Final overall survival efficacy results of ivosidenib for patients with advanced cholangiocarcinoma with IDH1 mutation: the phase 3 randomized clinical ClarIDHy trial","volume":"7","author":"Zhu","year":"2021","journal-title":"JAMA Oncol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.12659\/MSM.895040","article-title":"Diagnostic accuracy of serum CA19-9 in patients with cholangiocarcinoma: a systematic review and meta-analysis","volume":"21","author":"Liang","year":"2015","journal-title":"Med Sci Monit"},{"key":"B120","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1002\/CNCR.34854","article-title":"The association of carbohydrate antigen 19-9 response with radiologic response and survival in intrahepatic cholangiocarcinoma: a prospective cohort study","volume":"129","author":"Cai","year":"2023","journal-title":"Cancer"},{"key":"B121","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1002\/JSO.70071","article-title":"Characteristics of \u201cVery Early\u201d intrahepatic cholangiocarcinoma undergoing liver resection and its relationship with carbohydrate antigen 19-9","volume":"132","author":"Endo","year":"2025","journal-title":"J Surg Oncol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/S00595-023-02715-8","article-title":"Prognostic impact of pre- and postoperative tumor markers in patients with intrahepatic cholangiocarcinoma","volume":"54","author":"Okada","year":"2024","journal-title":"Surg Today"},{"key":"B123","doi-asserted-by":"publisher","first-page":"104170","DOI":"10.3748\/wjg.v31.i11.104170","article-title":"Cholangiocarcinoma: the era of liquid biopsy","volume":"31","author":"Kotsifa","year":"2025","journal-title":"World J Gastroenterol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"105079","DOI":"10.1016\/j.esmoop.2025.105079","article-title":"Precision oncology in biliary tract cancer: the emerging role of liquid biopsy","volume":"10","author":"de Scordilli","year":"2025","journal-title":"ESMO Open"},{"key":"B125","doi-asserted-by":"publisher","first-page":"1616064","DOI":"10.3389\/fcell.2025.1616064","article-title":"Circulating tumor DNA in cholangiocarcinoma: current clinical applications and future perspectives","volume":"13","author":"Wang","year":"2025","journal-title":"Front Cell Dev Biol"},{"key":"B126","doi-asserted-by":"publisher","first-page":"e2531373","DOI":"10.1001\/jamanetworkopen.2025.31373","article-title":"Circulating tumor DNA and tissue testing for pancreatobiliary tumors","volume":"8","author":"Mahadevia","year":"2025","journal-title":"JAMA Netw Open"},{"key":"B127","doi-asserted-by":"publisher","first-page":"13261","DOI":"10.1038\/s41598-019-49860-0","article-title":"Genotyping of circulating tumor DNA in cholangiocarcinoma reveals diagnostic and prognostic information","volume":"9","author":"Ettrich","year":"2019","journal-title":"Scientific Rep"},{"key":"B128","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.jmoldx.2025.08.009","article-title":"Validation and clinical utility of a pan-cancer circulating tumor DNA assay as a first-approach test","volume":"27","author":"Kanwar","year":"2025","journal-title":"J Mol Diagn"},{"key":"B129","doi-asserted-by":"publisher","first-page":"13219","DOI":"10.3390\/IJMS241713219","article-title":"Using cfDNA and ctDNA as oncologic markers: a path to clinical validation","volume":"24","author":"Dao","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B130","doi-asserted-by":"publisher","first-page":"332","DOI":"10.4251\/WJGO.V13.I5.332","article-title":"Liquid biopsy in cholangiocarcinoma: current status and future perspectives","volume":"13","author":"Rompianesi","year":"2021","journal-title":"World J Gastrointest Oncol"},{"key":"B131","doi-asserted-by":"publisher","first-page":"e2400443","DOI":"10.1200\/po-24-00443","article-title":"Detecting early recurrence with circulating tumor DNA in stage I-III biliary tract cancer after curative resection","volume":"9","author":"Yu","year":"2025","journal-title":"JCO Precis Oncol"},{"key":"B132","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/jhbp.1432","article-title":"The efficacy of bile liquid biopsy in the diagnosis and treatment of biliary tract cancer","volume":"31","author":"Miura","year":"2024","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"B133","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1136\/gutjnl-2021-325178","article-title":"Next-generation sequencing of bile cell-free DNA for the early detection of patients with malignant biliary strictures","volume":"71","author":"Arechederra","year":"2022","journal-title":"Gut"},{"key":"B134","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.annonc.2022.09.150","article-title":"The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancer","volume":"33","author":"Berchuck","year":"2022","journal-title":"Ann Oncol"},{"key":"B135","doi-asserted-by":"publisher","first-page":"1632630","DOI":"10.3389\/fonc.2025.1632630","article-title":"Preoperative assessment of longitudinal extent in hilar cholangiocarcinoma using noninvasive enhanced MR radiomics: a multicenter study","volume":"15","author":"Quan","year":"2025","journal-title":"Front Oncol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"9629","DOI":"10.1038\/s41598-025-92263-7","article-title":"Comparison of MRI and CT based deep learning radiomics analyses and their combination for diagnosing intrahepatic cholangiocarcinoma","volume":"15","author":"Cheng","year":"2025","journal-title":"Scientific Rep"},{"key":"B137","doi-asserted-by":"publisher","first-page":"e69906","DOI":"10.2196\/69906","article-title":"The application status of Radiomics-Based machine learning in intrahepatic cholangiocarcinoma: systematic review and meta-analysis","volume":"27","author":"Xu","year":"2025","journal-title":"J Med Internet Res"},{"key":"B138","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1159\/000547071","article-title":"Preoperative prediction of microvascular invasion in intrahepatic cholangiocarcinoma and its prognostic implications: a multicenter study","volume":"15","author":"Jang","year":"2026","journal-title":"Liver Cancer"},{"key":"B139","doi-asserted-by":"publisher","first-page":"111896","DOI":"10.1016\/j.ejrad.2024.111896","article-title":"An MRI-based radiomics model for preoperative prediction of microvascular invasion and outcome in intrahepatic cholangiocarcinoma","volume":"183","author":"Miao","year":"2025","journal-title":"Eur J Radiol"},{"key":"B140","doi-asserted-by":"publisher","first-page":"4204","DOI":"10.3390\/cancers15174204","article-title":"Radiomic analysis of intrahepatic cholangiocarcinoma: non-invasive prediction of pathology data: a multicenter study to develop a clinical\u2013radiomic model","volume":"15","author":"Fiz","year":"2023","journal-title":"Cancers"},{"key":"B141","doi-asserted-by":"publisher","first-page":"900478","DOI":"10.3389\/fonc.2022.900478","article-title":"CT-Based radiomics analysis for noninvasive prediction of perineural invasion of perihilar cholangiocarcinoma","volume":"12","author":"Zhan","year":"2022","journal-title":"Front Oncol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1007\/s00330-023-10108-1","article-title":"Radiomics using CT images for preoperative prediction of lymph node metastasis in perihilar cholangiocarcinoma: a multi-centric study","volume":"34","author":"Zhan","year":"2024","journal-title":"Eur Radiol"},{"key":"B143","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1002\/jmri.29390","article-title":"Intra- and peri-tumoral radiomics based on dynamic contrast Enhanced-MRI to identify lymph node metastasis and prognosis in intrahepatic cholangiocarcinoma","volume":"60","author":"Pan","year":"2024","journal-title":"J Magn Reson Imaging"},{"key":"B144","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1111\/liv.14763","article-title":"Machine-learning radiomics to predict early recurrence in perihilar cholangiocarcinoma after curative resection","volume":"41","author":"Qin","year":"2021","journal-title":"Liver Int"},{"key":"B145","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1007\/s12072-023-10487-z","article-title":"Artificial intelligence CT radiomics to predict early recurrence of intrahepatic cholangiocarcinoma: a multicenter study","volume":"17","author":"Song","year":"2023","journal-title":"Hepatol Int"},{"key":"B146","doi-asserted-by":"publisher","first-page":"5604","DOI":"10.1245\/s10434-024-15457-9","article-title":"Radiomics of intrahepatic cholangiocarcinoma and peritumoral tissue predicts postoperative survival: development of a CT-Based clinical-radiomic model","volume":"31","author":"Fiz","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"B147","doi-asserted-by":"publisher","first-page":"107167","DOI":"10.1016\/j.crad.2025.107167","article-title":"Radiomics of hepatopancreatobiliary cancer diagnosis, management, and future prospects","volume":"92","author":"Koku","year":"2026","journal-title":"Clin Radiol"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000001698","article-title":"Incorporating artificial intelligence into imaging for surveillance and diagnosis of liver cancer: innovations, challenges, and clinical translation","author":"Ronot","year":"2026","journal-title":"Hepatology"},{"key":"B149","doi-asserted-by":"publisher","first-page":"5042","DOI":"10.3390\/CANCERS14205042","article-title":"PET-uptake in liver metastases as method to predict tumor biological behavior in patients transplanted for colorectal liver metastases developing lung recurrence","volume":"14","author":"Dueland","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B150","doi-asserted-by":"publisher","first-page":"E20932","DOI":"10.1097\/MD.0000000000020932","article-title":"Comparison of magnetic resonance imaging and 18-fludeoxyglucose positron emission tomography\/computed tomography in the diagnostic accuracy of staging in patients with cholangiocarcinoma: a meta-analysis","volume":"99","author":"Huang","year":"2020","journal-title":"Medicine (United States)"},{"key":"B151","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jhep.2019.01.038","article-title":"18F-fluorodeoxyglucose positron emission tomography (18FDG-PET) for patients with biliary tract cancer: systematic review and meta-analysis","volume":"71","author":"Lamarca","year":"2019","journal-title":"J Hepatol"},{"key":"B152","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1136\/jim-2017-000472","article-title":"Preoperative staging of cholangiocarcinoma and biliary carcinoma using 18F-fluorodeoxyglucose positron emission tomography: a meta-analysis","volume":"66","author":"Hu","year":"2018","journal-title":"J Invest Med"},{"key":"B153","doi-asserted-by":"publisher","first-page":"4138","DOI":"10.1007\/s00261-021-03071-2","article-title":"Role of dual-time point 18F-FDG PET\/CT imaging in the primary diagnosis and staging of hilar cholangiocarcinoma","volume":"46","author":"Pang","year":"2021","journal-title":"Abdom Radiol"},{"key":"B154","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s00268-017-4192-3","article-title":"Diagnostic and prognostic role of 18-FDG PET\/CT in the management of resectable biliary tract cancer","volume":"42","author":"Ma","year":"2018","journal-title":"World J Surg"},{"key":"B155","doi-asserted-by":"publisher","first-page":"e26015","DOI":"10.1097\/MD.0000000000026015","article-title":"Prognostic value of metabolic parameters measured by pretreatment dual-time-point 18F-fluorodeoxyglucose positron emission tomography\/computed tomography in patients with intrahepatic or perihilar cholangiocarcinoma A STROBE study","volume":"100","author":"Hwang","year":"2021","journal-title":"Medicine (United States)"},{"key":"B156","doi-asserted-by":"publisher","first-page":"971","DOI":"10.21873\/anticanres.13201","article-title":"Impact of metabolic parameters of 18F-Fluorodeoxyglucose positron-emission tomography after hepatic resection in patients with intrahepatic cholangiocarcinoma","volume":"39","author":"Harimoto","year":"2019","journal-title":"Anticancer Res"},{"key":"B157","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.hpb.2024.09.012","article-title":"Prognostic value of resection margin and lymph node status in perihilar cholangiocarcinoma","volume":"27","author":"Koca","year":"2025","journal-title":"HPB"},{"key":"B158","doi-asserted-by":"publisher","first-page":"105446","DOI":"10.4254\/WJH.V17.I5.105446","article-title":"Progress in the application of fludeoxyglucose positron emission tomography computed tomography in biliary tract cancer","volume":"17","author":"Yin","year":"2025","journal-title":"World J Hepatol"},{"key":"B159","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1007\/S00261-024-04267-Y","article-title":"Cholangiocarcinoma imaging: from diagnosis to response assessment","volume":"49","author":"Cao","year":"2024","journal-title":"Abdom Radiol (NY)"},{"key":"B160","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1007\/S00261-023-03925-X","article-title":"Comparison of 18F-FDG PET\/MR and PET\/CT for pretreatment TNM staging of hilar cholangiocarcinoma","volume":"48","author":"Pang","year":"2023","journal-title":"Abdom Radiol (NY)"},{"key":"B161","doi-asserted-by":"publisher","first-page":"714","DOI":"10.3348\/kjr.2020.0689","article-title":"Additional value of integrated 18F-FDG PET\/MRI for evaluating biliary tract cancer: Comparison with contrast-enhanced CT","volume":"22","author":"Yoo","year":"2021","journal-title":"Korean J Radiol"},{"key":"B162","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1007\/S00259-019-04558-3","article-title":"Management implications of fluorodeoxyglucose positron emission tomography\/magnetic resonance in untreated intrahepatic cholangiocarcinoma","volume":"47","author":"Ferrone","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B163","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1007\/s00259-025-07264-5","article-title":"Comparative diagnostic performance of [68 Ga]Ga-FAPI PET\/CT and [18 F]FDGPET\/CT in biliary tract cancers: a systematic review and meta-analysis","volume":"52","author":"Msherghi","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B164","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/RLU.0000000000005112","article-title":"68Ga-FAPI-04 PET\/CT for the evaluation of cholangiocarcinoma comparison with 18F-FDG PET\/CT and abdominal 68Ga-FAPI-04 PET\/MR","volume":"49","author":"Zhang","year":"2024","journal-title":"Clin Nucl Med"},{"key":"B165","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.2967\/jnumed.122.265215","article-title":"Superior tumor detection for 68Ga-FAPI-46 versus 18F-FDG PET\/CT and conventional CT in patients with cholangiocarcinoma","volume":"64","author":"Pabst","year":"2023","journal-title":"J Nucl Med"},{"key":"B166","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S1470-2045(25)00299-2","article-title":"[68Ga]Ga-FAPI-46 PET accuracy for cancer imaging with histopathology validation: a single-centre, single-arm, interventional, phase 2 trial","volume":"26","author":"Pabst","year":"2025","journal-title":"Lancet Oncol"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000006310","article-title":"Optimizing Intrahepatic cholangiocarcinoma staging: comparison of [18F]FDG, [68Ga]Ga-FAPI, and [68Ga]Ga-Trivehexin PET\/CT imaging","author":"Denizmen Zorba","year":"2026","journal-title":"Clin Nucl Med"},{"key":"B168","doi-asserted-by":"publisher","first-page":"e695","DOI":"10.1097\/RLU.0000000000005877","article-title":"Comparable diagnostic value of 99mTc-FAPI-46 SPECT\/CT and 18F-FDG PET\/CT in cholangiocarcinoma: a case report","volume":"50","author":"Raeisi","year":"2025","journal-title":"Clin Nucl Med"},{"key":"B169","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1001\/JAMASURG.2023.6083","article-title":"Liver transplant as a treatment of primary and secondary liver neoplasms","volume":"159","author":"Gorji","year":"2024","journal-title":"JAMA Surg"},{"key":"B170","doi-asserted-by":"publisher","first-page":"e232932","DOI":"10.1001\/JAMASURG.2023.2932","article-title":"Long-term survival, prognostic factors, and selection of patients with colorectal cancer for liver transplant: a nonrandomized controlled trial","volume":"158","author":"Dueland","year":"2023","journal-title":"JAMA Surg"},{"key":"B171","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1097\/sla.0000000000006086","article-title":"The development of transplant oncology may worsen the liver gap and needs new technical options in liver transplantation","volume":"279","author":"Soubrane","year":"2023","journal-title":"Ann Surg"},{"key":"B172","doi-asserted-by":"publisher","first-page":"e96","DOI":"10.1016\/j.jhep.2024.04.024","article-title":"Normothermic perfusion of a human tumoral liver for 17 days with concomitant extracorporeal blood purification therapy: case description","volume":"81","author":"Cillo","year":"2024","journal-title":"J Hepatol"},{"key":"B173","doi-asserted-by":"publisher","first-page":"5214","DOI":"10.3390\/jcm13175214","article-title":"The rationale for combining normothermic liver machine perfusion with continuous renal replacement therapy to maintain physiological perfusate during Ex Vivo organ perfusion","volume":"13","author":"Nalesso","year":"2024","journal-title":"J Clin Med"},{"key":"B174","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1097\/tp.0000000000005039","article-title":"Full-left\/full-right liver splitting with middle hepatic vein and caval partition during dual hypothermic oxygenated machine perfusion","volume":"108","author":"Cillo","year":"2024","journal-title":"Transplantation"}],"container-title":["Transplant International"],"original-title":[],"link":[{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/ti.2026.15786\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T05:10:14Z","timestamp":1778130614000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/ti.2026.15786\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":174,"alternative-id":["10.3389\/ti.2026.15786"],"URL":"https:\/\/doi.org\/10.3389\/ti.2026.15786","relation":{},"ISSN":["1432-2277"],"issn-type":[{"value":"1432-2277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"article-number":"15786"}}